L-arginine supplementation normalizes bone turnover and preserves bone mass in streptozotocin-induced diabetic rats.

Journal of endocrinological investigation

Volumn 32, Issue 6, 2009, Pages 546-551

  Pennisi, P ^a   Clementi, G ^a   Prato, A ^a   Luca, T ^a   Martinez, G ^a   Mangiafico, R A ^a   Pulvirenti, I ^a   Muratore, F ^a   Fiore, C E ^a  

^a UNIVERSITY OF CATANIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; ARGININE; CALCIUM; COLLAGEN TYPE 1; COLLAGEN TYPE I TRIMERIC CROSS LINKED PEPTIDE; COLLAGEN TYPE I TRIMERIC CROSS-LINKED PEPTIDE; CREATININE; NITRIC OXIDE DONOR; OSTEOCALCIN; PEPTIDE;

ANIMAL; ARTICLE; BLOOD; BONE DENSITY; BONE REMODELING; DRUG EFFECT; EXPERIMENTAL DIABETES MELLITUS; INSULIN DEPENDENT DIABETES MELLITUS; MALE; METABOLIC BONE DISEASE; METABOLISM; NONPARAMETRIC TEST; PATHOLOGY; PHYSIOLOGY; RAT; SPRAGUE DAWLEY RAT;

ALKALINE PHOSPHATASE; ANIMALS; ARGININE; BONE DENSITY; BONE DISEASES, METABOLIC; BONE REMODELING; CALCIUM; COLLAGEN TYPE I; CREATININE; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 1; MALE; NITRIC OXIDE DONORS; OSTEOCALCIN; PEPTIDES; RATS; RATS, SPRAGUE-DAWLEY; STATISTICS, NONPARAMETRIC;

EID: 77449104501     PISSN: None     EISSN: 17208386     Source Type: Journal    
DOI: 10.1007/BF03346505     Document Type: Article

References (0)